BioSpace News Archive

Dr. Darlyne Bailey has been named Chair of the Board of Directors of Ultimate Medical Academy, a Tampa-based nonprofit higher education institution, effective immediately.

Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, reported financial results for the fourth quarter and year ended December 31, 2018 and provided a corporate update.

Array BioPharma Inc. announced that the National Comprehensive Cancer Network® has updated their Clinical Practice Guidelines in Oncology for Colon and Rectal Cancer to include BRAFTOVI® in combination with MEKTOVI® and an anti-EGFR antibody as a Category 2a treatment for patients with BRAFV600E-mutant metastatic colorectal cancer, after failure of one or two prior lines of therapy for metastatic disease.

Only one in six youth who visited the emergency department for psychiatric concerns saw a mental health professional

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., is proud to announce that researchers from Steven Henikoff’s laboratory have developed a novel epigenomic method, CUT&Tag, for high-throughput profiling of chromatin components in single cells on the ICELL8 Single-Cell System.

With a laser-like focus on innovation benefiting eyecare providers and consumers alike, the annual Vision Expo East will take place at the Javits Center in New York City, March 21-24.

Muno-Vax Biotechnologies, which has developed dynamic and effective nutritional supplements that help boost the body’s immune system, will attend Weight Management, Sports Nutrition, Vitamin & Hemp Solutions EPPS conference in Orlando.

Peroxfarma, the owner of Epaplus nutritional supplements, will attend this month’s Weight Management, Sports Nutrition, Vitamin & Hemp Solutions EPPS conference in Orlando.

Fressko and its premium glass- and bamboo-encased stainless steel flasks and infusers will attend this month’s Weight Management, Sports Nutrition, Vitamin & Hemp Solutions EPPS conference in Orlando.

BlockRules, the blockchain fintech company enforcing complex compliance rules directly on the blockchain, announces that the first security token powered by its technology will be for Verseon, a clinical-stage pharmaceutical company and BlockRules’ parent company.